Abbott Laboratories vs Pfizer, Inc. — Stock Comparison
Abbott Laboratories (ABT) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Abbott Laboratories scores ahead of Pfizer, Inc. on Q·Score (7.1 vs 6.2 out of 10), led by Sentiment (7.6 vs 5.3) and Valuation (8.6 vs 7). Pfizer, Inc. scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for ABT (+32.2%) than for PFE (+11.4%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $116.54 is 32% above current price.
⚠ earnings contracting 20% year-over-year.
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
ABT vs PFE: which stock scores better overall?
Based on Q·Score, Abbott Laboratories (ABT) scores 7.1/10 versus Pfizer, Inc. (PFE) at 6.2/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ABT or PFE?
Pfizer, Inc. (PFE) scores higher on Growth (5.1/10 vs 4.7/10). Abbott Laboratories reports revenue growth (7.8% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ABT or PFE more attractively valued?
Abbott Laboratories (ABT) scores higher on Valuation (8.6/10 vs 7/10). ABT trades at 14.6× P/E versus PFE at 9.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ABT vs PFE?
There are 24 analysts covering ABT with a consensus price target of $116.54, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ABT or PFE?
Abbott Laboratories (ABT) scores higher on Quality (7.7/10 vs 6.4/10). Net profit margin: ABT at 13.9%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ABT or PFE?
Abbott Laboratories (ABT) scores higher on Financial Health (7/10 vs 7/10). Market beta: ABT at 0.62, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ABT and PFE?
Abbott Laboratories (ABT) has a market capitalisation of $153.6B, while Pfizer, Inc. (PFE) has a market cap of $149.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ABT or PFE pay dividends?
ABT pays a dividend yield of 2.86%, while PFE pays a dividend yield of 6.56%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →